Smads are central mediators of signal transduction for the TGF␤ superfamily. However, the precise functions of Smad-mediated signaling pathways in early development are unclear. Here we demonstrate a requirement for Smad2 signaling in dorsoanterior axis formation during Xenopus development. Using two point mutations of Smad2 previously identified in colorectal carcinomas, we show that Smad2 ushers Smad4 to the nucleus to form a transcriptional activation complex with the nuclear DNA-binding protein FAST-1 and that the mutant proteins interact normally with FAST-1 but fail to recruit Smad4 into the nucleus. This mechanism of inhibition specifically restricts the dominant-negative activity of these mutants to the activin/Vg1 signaling pathway without inhibiting BMPs. Furthermore, expression of these mutants in Xenopus animal caps inhibits but does not abolish activin and Vg1 induction of mesoderm and in the embryo results in a truncated dorsoanterior axis. These studies define a mechanism through which mutations in Smad2 may block TGF␤-dependent signaling and suggest a critical role for inductive signaling mediated by the Smad2 pathway in Xenopus organizer function.
INTRODUCTION
Growth factors in the TGF␤ superfamily regulate a wide variety of developmental decisions (reviewed in Hogan, 1996; Hoodless and Wrana, 1997; Slack, 1994) . In particular, these factors have emerged as important inductive signals during gastrulation and the early establishment of the body plan. In Xenopus blastula-stage embryos, activins, Vg1, BMPs, and nodal-related factors have been shown to induce mesoderm and affect its patterning along the dorsal-ventral and anterior-posterior axes. For example, expression of activin or Vg1 on the ventral side of an embryo induces a second dorsal axis, suggesting that these factors can induce and pattern dorsal mesoderm and neural tissue (reviewed in Kessler and Melton, 1994; Heasman, 1997) . In Xenopus animal cap explants, activin and Vg1 induce dorsal mesoderm differentiation, consistent with this role. In contrast, BMPs can induce ventral mesoderm in animal caps and are capable of inhibiting neural differentiation in the animal cap ectoderm. Furthermore, it has been demonstrated that different types of mesoderm and endoderm can be induced depending on the concentration of activin. This has led to the model that activin can act as a morphogen such that a concentration gradient of the ligand will dictate the cell fate producing the diversity of patterning required in the embryo (reviewed in Smith, 1995; Neumann and Cohen, 1997) .
In recent years, an understanding of the mechanisms of TGF␤ signal transduction has provided insights into the function of TGF␤ signals in developing embryos (reviewed in Whitman, 1998) . TGF␤ family members interact with transmembrane receptor complexes which are composed of two distinct serine/threonine kinases, the type I and type II receptors (reviewed in Heldin et al., 1997) . Upon ligand binding, the type II receptor transphosphorylates and activates the type I receptor, which then transmits the signal into the cell by directly phosphorylating members of a family of intracellular proteins known as Smads (reviewed in Attisano and Wrana, 1998; Kretzschmar and Massagué, 1998; Heldin et al., 1997; Whitman, 1998) . Within the cell, signaling by TGF␤ family members separates into two distinct pathways, the BMP-induced pathway mediated by the receptor-regulated Smads 1, 5, and 8 and the TGF␤/ activin-induced pathway acting through Smads 2 and 3. Smad4, originally identified as a tumor suppressor in pancreatic cancers (Hahn et al., 1996) , can form heteromers with receptor-regulated Smads and acts as a common factor in signaling by both TGF␤/activins and BMPs (reviewed in Attisano and Wrana, 1998; Kretzschmar and Massagué, 1998; Heldin et al., 1997) . Thus, activation of signaling pathways by BMP or TGF␤/activin induces phosphorylation of receptor-regulated Smads, which permits association with Smad4 and translocation into the nucleus to regulate transcriptional responses. While Smad proteins are capable of interacting directly with DNA (Kim et al., 1997; Zawel et al., 1998; Yingling et al., 1997; Dennler et al., 1998; Labbé et al., 1998) , additional nuclear protein targets have been shown to be involved in formation of transcriptional activation complexes (Chen et al., 1996 Labbé et al., 1998; Zhou et al., 1998) . Little is known about the nuclear targets of BMP signaling. In response to activin/ TGF␤ signaling, however, Smad2 and Smad4 have been shown to interact with FAST proteins, members of the winged-helix family of transcription factors, that bind TGF-␤/activin-responsive DNA elements in the Mix.2 and goosecoid promoters (Chen et al., 1996 Labbé et al., 1998; Zhou et al., 1998) . Three related FAST proteins have been identified, the Xenopus and human factors, FAST-1, and the mouse factor, FAST2. Interestingly, although complexes containing FAST2, Smad2, and Smad4 can activate transcription, Smad3 can also form DNA-binding complexes with FAST-2 and Smad4 but these complexes inhibit transcriptional activation by the goosecoid element (Labbé et al., 1998) . Other promoters can be transcriptionally activated by Smad3 (Dennler et al., 1998; Yingling et al., 1997) , and this indicates that Smad2 and Smad3 can play distinct roles in response to TGF␤/activin signals. The pathways used by the TGF␤ family members, Vg1, and the nodals is not known since the receptors for these ligands remain to be identified. However, examination of biological responses to Vg1 and nodal expression in Xenopus suggests that these ligands stimulate an intracellular pathway related to activin.
The developmental effects of TGF␤ factors can be mimicked by components of their receptor and signal transduction pathways. Thus ectopic expression of wild-type or constitutively activated activin type I receptor can induce mesoderm in Xenopus animal caps . Similarly, overexpression of Smad1 and 5 induces ventral mesoderm in animal caps and can ventralize embryos, while Smad2 induces dorsal mesoderm in animal caps and ectopic axial structures in the ventral portion of the Xenopus embryo (Graff et al., 1996; Baker and Harland, 1996; Thomsen, 1996; Suzuki et al., 1997) . These observations are consistent with a role of Smad1 and 5 in the BMP pathway and Smad2 in activin/Vg1 signaling. However, unraveling the function of TGF␤ signals in early patterning has been hampered in part by a lack of reagents that specifically block signaling pathways at the ligand, receptor, or intracellular levels. Expression of dominant-negative type I or II activin receptors, for example, interferes with overall embryonic patterning in Xenopus, providing evidence that signals from activin receptors function in establishing the mesodermal germ layer (Hemmati-Brivanlou and Melton, 1992; Chang et al., 1997; Dyson and Gurdon, 1997; SchulteMerker et al., 1994) . However, the specificity of interference by these receptors is debatable since these receptors often disrupt BMP in addition to activin and Vg1 signaling (Hemmati-Brivanlou and Thomsen, 1995; Chang et al., 1997; Schulte-Merker et al., 1994) . The most specific disruption of signaling in Xenopus was provided by expression of the extracellular domain of the type II activin receptor (ActRIIBexd), which is able to block activin signaling while only marginally interfering with BMP signaling. This receptor inhibits initial mesoderm formation, indicating that activin does have an essential role in early Xenopus development (Dyson and Gurdon, 1997) . Downstream of TGF␤ receptors, a mutated version of Smad4 (DPC4) interferes with early mesodermal gene expression in Xenopus (Lagna et al., 1996) , but since this factor is the common signal transduction partner for Smad1 and Smad2, it is likely that its effects are on signaling by BMP or activin-related pathways. Interestingly, despite evidence indicating that activin plays a role in mesoderm induction in Xenopus, mice deficient in activin A and B are normal during comparable early stages of development, suggesting that activin may not regulate gastrulation and mesoderm formation in mammals (Matzuk et al., 1995) . However, mice deficient in the type I activin receptor, ActRIB (ALK4), or Smad2 do exhibit gastrulation defects, suggesting that an activin-like molecule acting through these components is required for gastrulation (Gu et al., 1998; Waldrip et al., 1998; Nomura and Li, 1998; Weinstein et al., 1998) .
We have utilized two Smad2 mutants, P445H and D450E (Eppert et al., 1996) , to investigate the function of the Smad2 signaling pathway in early Xenopus development. These mutants, identified in colorectal carcinomas, are defective in their ability to be phosphorylated (Eppert et al., 1996) and exhibit dominant-negative effects when expressed in Xenopus. In order to assess the specificity of the interference, we determined the mechanism of the dominant-negative activity. At the molecular level the mutants interact normally with the nuclear target FAST-1 but are unable to associate with and recruit Smad4 to the nucleus to form a transcriptional activation complex. Thus transcriptional complexes responding to activin/Vg1-like ligands are disrupted while other signaling pathways requiring Smad4 are not disturbed. In embryos expressing Smad2 P445H and D450E, mesoderm induction still occurs but complete axis formation is inhibited. This dominant-negative effect is specific to pathways which require Smad2 since the phenotypic effects of the mutants can be rescued by wild-type Smad2. These results suggest a mechanism through which mutations in Smad2 may block signaling during the development of cancer and show that inhibition of the Smad2 signaling pathway interferes with dorsal axis formation.
MATERIALS AND METHODS

Construction of Vectors
Expression constructs for Smad4, Smad2, and the mutants (P445H and D450E) ActRIIB and ALK4 (ActRIB) were previously described (Eppert et al., 1996; Macías-Silva et al., 1996; . For expression of FAST-1 in mammalian cells, myctagged FAST-1 (Chen et al., 1996) was subcloned into pCMV5. For yeast two-hybrid assays, wild-type and mutant versions of Smad2 and Smad4 were subcloned into pGBT9 (Clontech) to generate GAL4 DNA-binding domain fusion proteins. For GAL4 activation domain fusions, full-length FAST-1 and Smad 4 were subcloned into pGAD424 (Clontech).
Affinity-Labeling and Phosphate Labeling
For receptor interaction and phosphorylation studies, COS-1 cells were transiently transfected using diethylaminoethyl (DEAE) dextran. For phosphate labeling, cells were incubated with 32 PO 4 as previously described . Affinity-labeled cells were incubated with 100 pM [
125 I]activin in medium containing 0.2% fetal calf serum at 37°C for 30 min and the receptors were cross-linked to the ligand as previously described (Macías-Silva et al., 1996) . Cells were lysed in lysis buffer containing 10% glycerol (Wrana et al., 1994) and subjected to immunoprecipitation with anti-Flag M2 monoclonal antibody (IBI, Eastman Kodak) followed absorption to protein G-Sepharose (Pharmacia). Immunoprecipitates or aliquots of total lysates were separated by SDS-PAGE and visualized by autoradiography.
Electrophoretic Mobility Shift Assays (EMSA)
Transiently transfected COS-1 cells were homogenized in buffer containing 25% glycerol, 50 mM Tris-HCl, pH 8.0, 100 mM KCl, 2 mM DTT, 2 mM sodium vanadate, 10 mM sodium pyrophosphate, and 50 mM sodium fluoride. The homogenate was centrifuged twice (13,000g) for 10 min at 4°C and stored at Ϫ80°C. For the EMSA, extracts (5 g of protein) were incubated in a 20-l reaction volume on ice for 10 min in 20 mM Hepes, pH 7.9, 20% glycerol, 0.2 mM EDTA, 2 mM DTT, 7.2 mM MgCl 2 , and 2 g poly(dI-dC). A radiolabeled ARE oligonucleotide probe (Huang et al., 1995) was added (approximately 40,000 cpm or 20 fmol) and incubation continued for 30 min. For supershift assays, antibodies were added with the ARE oligonucleotide. The protein-DNA complexes were separated on a 5% acrylamide gel and visualized as previously described (Huang et al., 1995) .
Immunofluorescence
COS-1 cells were transiently transfected with various combinations of untagged Smad4, Flag-tagged Smad2, and myc-tagged FAST-1 (full-length) using calcium phosphate-DNA precipitatemediated transfection. Cells were fixed in 4% paraformaldehyde and permeabilized as described previously . Cells were blocked in 10% goat serum and incubated overnight at 4°C with anti-myc polyclonal antibody, A-14 (1 g/ml; Santa Cruz Biotechnology), anti-myc monoclonal antibody, 9E10 (ATCC), anti-Flag monoclonal antibody, M2 (10 g/ml), or a Smad4 polyclonal antibody generated to a glutathione S-transferase (GST) fusion protein containing the nonconserved region of Smad4. Cells were washed in phosphate-buffered saline and incubated with Texas red (TR)-conjugated goat anti-rabbit IgG and fluorescein isothiocynate (FITC)-conjugated goat anti-mouse IgG (1:200 dilution; Jackson Immunologicals) as secondary antibodies. Images were obtained using a Leica confocal microscope.
Embryological Methods
Mesoderm induction assays in animal caps and RT-PCR were previously described (Horb and Thomsen, 1997) . For activin treatment, caps were cultured with conditioned medium containing mouse activin A (PIF) (Sokol and Melton, 1991) . Lineage tracing with ␤-galactosidase was performed by fixing embryos in MEMFA (0.1 M Mops, pH 7.4, 2 mM EGTA, 1 mM MgSO 4 , 3.7% formaldehyde) for 30 min at room temperature, followed by three washes in 1ϫ PBS and then incubation at 37°C in 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 2 mM MgCl 2 , and 1 mg/ml X-gal. In situ hybridization was performed as described (Harland, 1991) . For histology, embryos were fixed in MEMFA followed by 1 h in Bouin's fixative, dehydrated, mounted in paraplast, and sectioned at 8 m ( Thomsen and Melton, 1993) .
RESULTS
Expression of Smad2 Mutants Perturbs Early Patterning in Xenopus Embryos
Smad2 transduces signals from type I TGF␤ and activin receptors and our previous work has shown that several Smad2 mutants isolated from colorectal tumors do not respond to signals from type I TGF␤ receptors, nor do they induce mesoderm in Xenopus animal caps (Eppert et al., 1996) . To gain insights into the function of Smad2 in early development and to examine the mechanism through which mutations may result in cancer, we focused on two Smad2 missense mutants, Smad2 P445H and Smad2 D450E, which harbor mutations in the MH2 domain and change proline 445 to histidine and aspartic acid 450 to glutamic acid, respectively. To test whether the mutants might display dominant-interfering properties, we examined the ability of these mutants to interfere with activin signaling in the well-characterized system, Xenopus ectodermal (animal cap) explants. In this assay, treatment of the animal caps with activin resulted in elongation, reflecting the cellular movements associated with anterior-posterior extension, while untreated caps remained spherical (Fig.  1A) . In contrast, when embryos were injected with mRNA encoding either of the Smad2 mutants prior to isolation of the caps, elongation in response to activin was abolished.
We next investigated the inhibitory effects of the Smad2 mutants on the molecular responses of animal caps to Vg1 and activin by RT-PCR. We analyzed a panel of markers which are induced in response to Vg1 or activin in animal caps and which represent the diversity of mesodermal cell types which can occur. Cerberus and chordin, which mark anterior endoderm and head mesoderm (Sasai et al., 1995; Bouwmeester et al., 1996) , were strongly induced by treatment with activin and this induction was potently inhibited by either P445H or D450E (Fig. 1B) . Moreover, induction of cerberus and chordin by processed Vg1 (BVg1; Thomsen and Melton, 1993) was also inhibited by the mutants, demonstrating that Smad2 mediates signals by both activin and Vg1. Induction of the Spemann organizer genes, Xlim-1 and goosecoid, were inhibited in the case of activin but this inhibition was not as strong with Vg1. Since the Vg1 ligand was produced by injection of the mRNA into the embryos, this may reflect differences in ligand concentrations. Induction by activin or Vg1 of the ventrolateral mesoderm markers Xhox3 and Xwnt-8 and the general mesoderm marker brachyury (Xbra) was affected to a lesser degree although some inhibition was still observed (Fig. 1B ). These results demonstrate that P445H and D450E have dominant-negative properties consistent with a role for Smad2 in activin and Vg1 signaling. Furthermore, although activin/Vg1 signaling is disrupted by the mutants, this inhibition is not complete, suggesting that the mutants do not completely block these signaling pathways.
The Mutants P445H and D450E Interact with ALK4 but Are Not Phosphorylated
Expression of mutant components of TGF␤ signaling pathways, such as ligands or receptors, often disrupts both BMP and activin signaling pathways. To assess the specificity of the Smad2 mutants, we examined the mechanism through which the mutants exert their dominant-negative action. Smad2 is regulated by rapid phosphorylation in response to both TGF␤ and activin signaling, and in the case of TGF␤, this is directly mediated by the TGF␤ type I receptor kinase (Macías-Silva et al., 1996) . However, TGF␤ receptors are absent during early Xenopus development (Bhushan et al., 1994) and it is more likely that the Smad2 mutants function by disrupting endogenous, activin-like signals. Thus, we focused our investigations on the role of wild-type and mutant Smad2 in activin signaling.
Previous studies with the mutants P445H and D450E showed that they are not phosphorylated in response to TGF␤ (Eppert et al., 1996) . In order to examine phosphorylation of the mutants by activin signaling, COS-1 cells were transiently transfected with flag-tagged versions of wildtype, P445H, or D450E Smad2, together with either the wild-type or a constitutively active form of the type I activin receptor, ALK4 (also known as ActRIB). Cells were incubated with 32 PO 4 and immunoprecipitated Smad2 was analyzed. Similar to the results with TGF␤ signaling, nei-
FIG. 1.
Smad2 mutants function as dominant-negatives to inhibit activin/Vg1 signaling. (A) Morphogenetic movements in response to activin are blocked by Smad2 mutants. Animal caps were injected with mRNA encoding the Smad2 mutants P445H or D450E (3 ng) and treated with conditioned medium containing activin. Caps were assessed when control embryos reached neurula stage 18. (i) Untreated caps, (ii) activin-treated caps, (iii) caps injected with P445H mRNA and treated with activin, (iv) caps injected with D450E mRNA and treated with activin. (B) Induction of mesodermal marker genes by Vg1 or activin was inhibited by Smad2 mutants. The animal pole of fertilized eggs was injected with mRNA encoding vector sequences (Ϫ), P445H, or D450E. In the BVg1 assays, 10 pg of BVg1 mRNA was subsequently injected into one animal pole blastomere at the 8-to 16-cell stage. Animal caps were excised at stage 8 -9 and harvested at stage 11 (midgastrula). Expression of mesodermal marker genes, as indicated, was scored by RT-PCR. Efl-␣ expression is a control for RNA recovery. The experiment was repeated at least three times and representative results are presented. RTϩ exposures for organizer genes in the embryo were deliberately underloaded to avoid overexposure.
ther the P445H nor the D450E mutants were phosphorylated in response to activin signaling ( Fig. 2A) . Since phosphorylation of receptor-regulated Smads by ser/thr kinase receptors leads to their dissociation from the receptor (Macías-Silva et al., 1996) , we investigated whether the Smad2 mutants might block activin signaling by forming a stable complex with the receptors. COS-1 cells were transiently transfected with flag-tagged wild-type, P445H, or D450E Smad2, together with the activin type II receptor, ActRIIB, and either the wild-type or kinase-deficient ALK4. The kinase-deficient version was included since in the case of T␤RI, catalytically inactive receptor is required to trap the transiently associated Smad2 substrate (Macías-Silva et al., 1996) . To detect the interaction, the receptors were 125 I]activin and cell lysates were subjected to immunoprecipitation with anti-flag M2 antibody as previously described (Macías-Silva et al., 1996; Attisano et al., 1992) . Receptor complexes were visualized by SDS-PAGE and autoradiography (left). To confirm equivalent levels of receptor expression, total cell lysates were analyzed by SDS-PAGE (right).
affinity-labeled with [
125 I]activin and immunoprecipitates of Smad2 were analyzed. Contrary to our hypothesis, wildtype activin receptors did not coprecipitate with either wild-type Smad2 or the mutants, indicating that the mutations do not stabilize the association with the wild-type receptor (Fig. 2B) . However, in cells expressing a kinasedeficient ALK4, comparable levels of receptor complexes were detected coprecipitating with Smad2 in all cases, indicating that the mutations do not cause major conformational changes that prevent interaction with the type I kinase. These observations are in contrast to our previous report that phosphorylation site mutants of Smad2 interact stably with the TGF␤ receptor (Macías-Silva et al., 1996) . To determine whether this is a feature of the activin receptor, we also tested the interaction of Smad2(3SA), a mutant in which the phosphorylation site at the C-terminus is mutated (Macías-Silva et al., 1996) . Similar to the P445H and D450E mutants, we observed that Smad2(3SA) stably associated with activin receptor complexes containing kinase-deficient ALK4 but not wild-type type I receptors (data not shown). Furthermore, we found that the P445H and D450E mutants interacted stably with wild-type TGF␤ receptors, providing a potential mechanism for blocking TGF␤ signaling (S. Abdollah and J.L.W., unpublished results). It is currently unclear why phosphorylation mutants of Smad2 do not associate stably with the activin receptor. Nevertheless, these data suggest that the mutants may have additional dominant-negative activities that do not involve preventing access of wild-type Smad2 to receptors.
Smad2 Mutants Fail to Recruit Cytosolic Smad4 into a Nuclear Complex with FAST-1
Upon activin stimulation, Smad2 associates with Smad4, accumulates in the nucleus, and interacts with the DNAbinding protein, FAST-1 or FAST2 (reviewed in Attisano and Wrana, 1998; Kretzschmar and Massagué , 1998; Heldin et al., 1997; Whitman, 1998) . Smad2, Smad4, and either FAST-1 or FAST2 are components of a TGF␤/activin response factor (T/ARF), which binds to the activin response element (T/ARE) located in the promoter of the Xenopus Mix.2 or mammalian goosecoid genes, respectively (Huang et al., 1995; Chen et al., 1997; Labbé et al., 1998) . To determine whether any of these functions of Smad2 are affected by the point mutations, we examined the formation of an ARF in response to activin signaling by EMSA. In extracts from Cos cells expressing flag-tagged Smad2, Smad4, and myc-tagged Xenopus FAST-1, a distinct ARF was observed which was enhanced in the presence of constitutively active ALK4 (Fig. 3A) . This complex was shifted by preincubation with myc, flag, or Smad4 antibodies, confirming that the ARF contains a complex of all three components Liu et al., 1997) . We then examined whether the Smad2 mutants could support formation of an ARF. In contrast to wild-type Smad2, cells expressing the mutant P445H formed only a minimal amount of ARF, and this was not enhanced in the presence of constitutively active receptor (Fig. 3A) . Furthermore, we were unable to detect any ARF formation in cells expressing Smad2 D450E. Thus, both mutants are defective in their ability to support formation of a higher order DNA-binding complex that is required for activin-induced transcriptional activation of the Mix.2 promoter.
Previous studies have shown that Smad2, but not Smad4, directly interacts with FAST-1 and that Smad2 functions to recruit Smad4 into a complex with FAST-1 to form an ARF. To determine how the mutants disrupt ARF formation we examined the interactions of the mutant proteins with Smad4 and FAST-1 using a yeast two-hybrid system. Interestingly, both the wild-type and the mutant forms of Smad2 interacted equally well with FAST-1 (Fig. 3B) , while no interaction between FAST-1 and Smad4 could be detected, supporting previous observations Liu et al., 1997) . However, when we tested the interaction between the Smad2 mutants and Smad4, wild-type Smad2 interacted strongly with Smad4 while the mutant D450E did not, and the mutant P445H interacted only weakly (Fig. 3C) , correlating with our observation that a small amount of ARF was formed with this mutant. This suggests that the Smad2 mutants interact normally with FAST-1 but are unable to recruit Smad4 into a complex with FAST-1.
To better understand the mechanism by which Smad2 functions in the recruitment of Smad4 to FAST-1 and to confirm the dominant-negative action of the Smad2 mutants in intact cells, we examined their subcellular localization by immunofluorescence. This also allowed us to examine whether the nuclear localization of Smad2 is affected by the mutations in P445H and D450E. To characterize this whole cell system, we first tested the interactions of these proteins using wild-type versions. COS-1 cells were transfected with various combinations of myctagged FAST-1, flag-tagged Smad2, and untagged Smad4 and the proteins were localized by confocal microscopy. As previously demonstrated (Chen et al., 1996) , FAST-1 is almost exclusively nuclear and its localization is unaffected by expression of constitutively active ALK4 (Fig. 4C and data not shown). In cells expressing Smad2 alone, Smad2 can be seen throughout the cell in equilibrium between the cytoplasm and the nucleus (Fig. 4A) and activation of signaling pathways through either the TGF␤ or the activin receptor resulted in accumulation of Smad2 protein in the nucleus (data not shown; Baker and Harland, 1996; Macías-Silva et al., 1996) . Interestingly, coexpression of Smad2 and FAST-1 in the same cell resulted in a dramatic shift of Smad2 into the nucleus that occurred independent of receptor signaling (Figs. 4D-4F ), suggesting that overexpression of a nuclear target can shift the equilibrium of the Smad2 protein in the absence of signaling. Furthermore, the colocalization of Smad2 and FAST-1 (indicated by yellow fluorescence in Fig. 4F ) suggests that phosphorylation is not absolutely required for association. This is consistent with the strong interactions that we observed between these two proteins in yeast, which do not possess a TGF␤ signaling system. In contrast, in cells expressing Smad4 alone, Smad4 was observed predominantly in the cytoplasm (Figs. 4B and  5A ). Furthermore, coexpression of Smad4 with FAST-1 did not result in any shift in the localization of Smad4 (Figs.  4G-4I ), supporting the observation that Smad4 does not interact with FAST-1. However, in the presence of Smad2 and FAST-1, Smad4 colocalized with Smad2 in the nucleus, (Figs. 4J and 4K , and yellow staining in L), supporting the model that Smad2 is required to recruit Smad4 from the cytoplasm into a nuclear complex with FAST-1 (Liu et al., 1997) .
We next used this assay to examine the interactions of the Smad2 mutants. Similar to wild-type Smad2, in cells expressing either of the mutants alone, the protein was distributed throughout the cell (Figs. 5B and 5C ). Furthermore, coexpression of either Smad2 mutant with FAST-1 resulted in nearly exclusive localization of the mutant protein in the nucleus (Figs. 5D-5I ), supporting our observations that these point mutations do not disrupt interactions with FAST-1. However, expression of Smad4 together with FAST-1 and either Smad2 mutant did not result in the nuclear accumulation of Smad4 (Fig. 5J-5O ), in contrast to results obtained with wild-type Smad2 (Figs. 4J-4L ). Together our results clearly demonstrate that Smad2 functions to recruit Smad4 into a nuclear transcription complex (B) FAST-1 directly interacts with wild-type and mutant Smad2 but not Smad4. A yeast strain containing a ␤-galactosidase reporter gene driven by the GAL4 promoter was transformed with FAST-1 fused to the activation domain (AD) of GAL4 and wild-type (Smad2) or mutant (P445H or D450E) Smad2 or Smad4 (S4) fused to the GAL4 DNA-binding domain (BD). ␤-galactosidase activity was measured and the relative activity was plotted. (C) Smad2 mutants do not interact with Smad4. Yeast were transformed with the GAL4 DNA-binding domain (BD) alone or fused to wild-type (Smad2) or mutant (P445H and D450E) Smad2 together with the GAL4 activation domain (AD) alone (Ϫ) or fused to Smad4 (S4). ␤-Galactosidase activity was measured and the relative activity was plotted.
FIG. 4.
Smad4 requires Smad2 for nuclear localization and interaction with FAST-1. COS-1 cells were transiently transfected with combinations of flag-tagged Smad2, Smad4, and myc-tagged FAST-1. Smad2 protein was detected with a monoclonal anti-flag antibody with a FITC anti-mouse secondary antibody (green) and Smad4 protein was visualized using a polyclonal anti-Smad4 antibody with a Texas red anti-rabbit secondary antibody (red). For FAST-1, either an anti-myc monoclonal (green) or an anti-myc polyclonal antibody (red) was used as required for double labeling. The expressed proteins were visualized by immunofluorescent confocal microscopy. with FAST-1 and show that the mutant proteins, while retaining the capacity to interact with FAST-1, are not capable of recruiting Smad4 into a nuclear complex. Thus, we propose that overexpression of these mutant proteins may function specifically to block nuclear targets of Smad2 which are activated by activin-like signaling during early development. Importantly, these mutants are unlikely to interfere with the function of Smad4, which acts in both activin and BMP signaling pathways.
Expression of the Smad2 Mutants Disrupts Axis Formation
To examine the phenotypical effects of reducing activin or activin-like signals during embryonic development, we expressed these mutants in Xenopus embryos. Targeted expression of either P445H or D450E within the dorsal marginal zone resulted in axis truncation including a loss of obvious head structures (Figs. 6A and 6C ). Embryos injected with D450E displayed a slightly higher frequency (46%, n ϭ 127) of the truncated phenotype compared to P445H (37%, n ϭ 121), suggesting that D450E may be a stronger dominant-negative. Since Smad3 can also mediate activin/ TGF␤ signals, we made mutations of Smad3 at positions corresponding to the P445H and D450E mutations in Smad2. Expression of these Smad3 mutants also resulted in truncations when injected dorsally, identical to those observed with Smad2 (data not shown). Interestingly, the truncations observed with Smad2 mutants were highly dependent on the precise targeting of expression to the organizer and were generated only when the mutants were expressed in tissues at anterior positions in the embryo. Expression of these dominant negatives in ventral tissues, trunk, or tail had no effect demonstrating that BMP signaling was not disrupted by the mutant proteins (Figs. 6B and  6D ). This supports the biochemical mechanism of action for these mutants, indicating that BMP signaling is not affected. These results contrast with previous studies in which expression of truncated activin receptors resulted in strong suppression of mesoderm formation (HemmatiBrivanlou and Melton, 1992; Chang et al., 1997) . However, these receptors inhibit BMP signaling and in addition may more strongly inhibit activin signaling. In our experiments, we did not block mesoderm formation; however, when higher doses of mutant RNA (Ͼ 4 ng) were employed, we observed further dorsal axis truncation (Fig. 6E) , indicating that these mutants can also partially inhibit trunk formation. Importantly, coinjection of wild-type Smad2 (0.5 ng) along with the mutant Smad2 (D450E) into the dorsal region was able to rescue the truncations (Fig. 6F) , demonstrating that the mutants are specific dominant-negative inhibitors of the Smad2 signaling pathway. Together our results suggest that the mutants do not completely block all mesoderm inducing activities. However, complete axis formation is sensitive to inhibition of the Smad2 pathway, supporting a role for an activin or activin-like signal in the induction of the entire range of mesodermal cell types required for normal development.
DISCUSSION
We have utilized two mutations of Smad2, identified in colorectal carcinomas, to examine requirements for Smad2 signaling during early Xenopus development. We show that the receptor-regulated Smad, Smad2, directs interactions with the nuclear factor FAST-1, by recruiting Smad4 into nuclear transcription complexes. We further demonstrate that Smad2 point mutants function as dominant-negative proteins by preventing recruitment of Smad4 from the cytoplasm into downstream nuclear complexes. Expression of these specific dominant-negative Smad2 mutants in embryos at moderate doses inhibits anterior development but has little or no effect on trunk and tail formation. In addition, expression of the mutant proteins in Xenopus animal caps inhibits the induction of many organizer genes such as cerberus, chordin, and goosecoid in response to activin and Vg1. This inhibition is limited, indicating that activin/Vg1 signaling is not completely blocked by the mutants and suggests that these mutants reduce but do not abolish signaling. Activin and Vg1 have been extensively characterized as general mesoderm inducers in Xenopus, but our results now further demonstrate that high levels of FIG. 5. Smad4 does not accumulate in the nucleus in the presence of the Smad2 mutants, P445H and D450E. COS-1 cells were transfected with combinations of flag-tagged Smad2 mutants, P445H, D450E, Smad4, and myc-tagged FAST-1. The expressed proteins were visualized by immunofluorescent confocal microscopy as described in the legend to an activin/Vg1-like ligand, mediated through Smad2, can regulate anterior development.
Mechanism of Smad2 Dominant-Negative Activity
Smad2 is distributed throughout the cell but accumulates in the nucleus in response to ligand signaling (Macías-Silva et al., 1996) . In contrast, Smad4 is predominantly localized in the cytosol (Liu et al., 1997) . Phosphorylation of Smad2 by the type I receptor leads to association with Smad4 and nuclear translocation. Once in the nucleus, Smad2 and Smad4 complex with the nuclear factors FAST-1 or FAST2 to form an ARF Labbé et al., 1998; Zhou et al., 1998) which acts as a transcriptional activator to regulate gene expression (Liu et al., 1997; Labbé et al., 1998; reviewed in Attisano and Wrana, 1998; Kretzschmar and Massagué , 1998; Heldin et al., 1997; Whitman, 1998) . Transcriptional activation may occur through the association of Smad proteins with coactivators such as CBP/P300 and MSG-1 (Janknecht et al., 1998; Feng et al., 1998; Topper et al., 1998; Shioda et al., 1998) . Here, we have demonstrated, by examining subcellular localization, that FAST-1 expression promotes nuclear localization of Smad2. In contrast, FAST-1 does not interact directly with Smad4 and nuclear accumulation of Smad4 occurs only in the presence of Smad2. These observations support Liu et al. (1997) and indicate that Smad2 is required to usher Smad4 into the nucleus and that Smad2 mediates the interaction of Smad4 with its downstream targets. Since activation of Smad1 by BMPs also leads to interaction with Smad4 (Lagna et al., 1996) , BMP-regulated Smads may function in a similar manner to recruit Smad4, a general partner of receptorregulated Smads, into BMP-specific nuclear complexes. Therefore, by controlling the interaction of Smad4 with downstream targets, the receptor-regulated Smads play a critical role in maintaining the specificity of gene responses to a particular ligand.
At the molecular level, the Smad2 mutants P445H and D450E interact with the type I activin receptor, but phosphorylation is defective and association with Smad4 is   FIG. 6 . Expression of the Smad2 mutants inhibits dorsoanterior axis formation. Smad2 P445H (A) or Smad2 D450E (C) mRNA was injected (3 ng) into the subequatorial dorsal marginal zone (DMZ) at the 4-to 8-cell stage. The injected cells of embryos were lineage traced by coinjection of mRNAs for ␤-galactosidase (␤-gal) and the mutant Smad2, followed by staining for ␤-gal activity (blue cells). Positive staining for ␤-gal was noted in the anterior region of all headless embryos. Coinjection of the Smad mutants and ␤-gal mRNAs into the ventral marginal zone (B and D) shows normal embryonic development with lineage-labeled cells populating the trunk, ventral, and tail regions. (E) Expression of D450E at high levels causes partial disruption of trunk development. Mutant Smad2 D450E mRNA (4.5 ng) was targeted to the dorsal marginal zone of four cell embryos (2.25 ng in each of two blastomeres). Rated according to the dorsoanterior index (DAI; Kao and Elinson, 1988) these embryos had an average DAI of 2.2 (n ϭ 19). Note that some embryos are curved laterally due to an artifact of fixation, not incomplete gastrulation. (F) Coexpression of wild-type Smad2 (0.5 ng total) rescued defects caused by 4.5 ng of mutant D450E (average DAI ϭ 3.8, n ϭ 19). Most had normal heads and all had a full body axis. These results demonstrate that mutant D450E acts in a dominant-negative manner at the phenotypic level. Similar results were observed with mutant P445H (data not shown).
blocked. Although the mutants are able to interact with FAST-1, ARF formation is disrupted and Smad4 is not recruited into a nuclear complex. This further demonstrates that nuclear localization of Smad4 requires physical association with Smad2 and that Smad4 is required for efficient formation of an activin-induced transcriptional activation complex (Liu et al., 1997; Chen et al., 1997; Labbé et al., 1998) . Based on these features we propose that ectopic expression of Smad2 mutants in Xenopus embryos causes dominant-negative inhibition by titrating DNA-binding proteins into transcriptionally nonfunctional nuclear complexes which lack Smad4 (Fig. 7) . Since Smad4 is a common component of TGF␤ and BMP signaling pathways, this suggests that the Smad2 mutants do not interfere with BMP signaling, consistent with our observation that expression of the Smad2 mutants in the ventral marginal zone did not perturb ventral patterning by endogenous BMP signals. Furthermore, since receptor-regulated Smads interact with specific nuclear targets to elicit distinct, biological responses, these mutations provide specific dominantnegative activity for activin-like receptor pathways.
The Smad2 Mutants Reduce but Do Not Block Activin Signaling
The mutants P445H and D450E were originally identified in sporadic colorectal tumors, indicating that disruption of TGF␤ signaling can result in loss of sensitivity to negative growth regulation. The dominant-negative effects of the mutants may provide a mechanism through which inhibition of TGF␤ signaling could result in loss of growth inhibition. However, this is uncertain since, in the case of D450E, the mutation was accompanied by a loss of heterozygosity implied by the absence of wild-type message. Thus, this mechanism of dominant-negative activity may function only when the mutant is expressed at high levels relative to the wild-type protein.
The extent to which these dominant-negative mutants can inhibit Smad2 functions is unclear. Mesoderm induction by activin or Vg1 in animal caps was inhibited but not abolished in the presence of the Smad2 mutant proteins. The possibility exists that other pathways can overcome dominant-negative inhibition by the Smad2 mutants in some circumstances and thereby reveal inductive events which absolutely require functional Smad2. However, it is more likely that the Smad2 mutants act as weak dominantnegatives that reduce the level of Vg1 or activin-like signaling. It is well established that activin and BMPs can function in a concentration-dependent manner to effect cell fate decisions (Smith, 1996; Wilson et al., 1997) . High levels of activin signaling are able to induce dorsoanterior markers such as Goosecoid in animal explant cultures while lower levels can induce mesoderm with a more ventral character, reflected by expression of Xlhbox6 and Xbra (Green et al., 1992) . Furthermore, it is thought that in the embryo, activin or an activin-like factor functions as a morphogen to form a concentration gradient (reviewed in Neumann and Cohen, 1997) . In animal cap explants treated with activin or BVg1, we observed that the Smad2 mutant proteins inhibited induction of dorsoanterior markers, such as chordin and cerberus, more consistently and more severely than ventral markers such as Xwnt-8. This observation suggests that dorsoanterior markers are more sensitive to inhibition and may reflect a lower level of ligand signaling in animal caps expressing the mutant proteins. Thus, these mutants allow us to examine during development the functions of a specific subset of Vg1/activin-like responses that require high levels of ligand signaling.
Smad2 Signaling Is Required for Axis Formation
Due to the incomplete but specific nature of the inhibition, these mutants provide a unique opportunity to examine the effects of reducing activin-like signals in the embryo without completely disrupting mesoderm formation. Interestingly, we observed that expression of Smad2 mutants in the dorsal marginal zone of Xenopus embryos blocked complete axis formation. This phenotype was highly dependent on the precise targeting of mutant Smad2 expression to the organizer. If the organizer was not targeted, the tadpoles routinely developed normally. This points to a crucial role of a Smad2 signaling pathway for the induction of anterior axial structures while inhibition of activin/Vg1 activity in other regions is less critical. Thus, expression of the Smad2 mutants in the embryo may function to reduce signaling in all cells, resulting in a shift in the signal gradient such that the highest concentrations are never achieved. This is supported by expression of extremely large amounts of the mutant proteins in embryos which resulted in further axial truncations (see Fig. 6 ).
It is also interesting to note that expression of the mutants in the marginal zone of Xenopus sometimes reduced but did not abolish Xbra expression and delayed gastrulation movements (data not shown). However, if expression was not targeted to the organizer, embryos with slowed rates of gastrulation eventually finished blastopore closure, finished axial elongation, and recovered. This possibly reflects the presence of additional signals in the ventral marginal zone, such as BMPs, which can compensate for reduced activin signaling. Embryos expressing a secreted form of the activin type II receptor, ActRIIBexd, which inhibits activin but only minimally affects BMP signaling, also experience a delay in Xbra induction and yield anterior truncations and perturbations in trunk development (Dyson and Gurdon, 1997) . In addition, delays in gastrulation similar to the Smad2 effect have been noted for Smad4 dominant-negative mutants (Lagna et al., 1996) . However, in this case axial truncations were never observed (G. Lagna and A. Hemmati-Brivanlou, personal communication) , suggesting that disruptions induced by Smad2 mutants are not secondary to delays in gastrulation.
Similar mutations in Smad3 also inhibit axial development, indicating that the mutations identified in Smad2 may also affect Smad3 functions. Interestingly, mice lack-ing Smad3 are normal at birth, indicating that Smad3 is not required for embryonic development in mammals (Zhu et al., 1998) . However, expression of the Smad3 mutant proteins may be able to inhibit Smad2 functions since Smad3 can form complexes with Smad4 and nuclear DNA-binding proteins, such as FAST-1 and FAST2 (Labbé et al., 1998) . Thus while the role of Smad3 in Xenopus development remains to be established, the mutations in Smad3 are likely to function identically to the Smad2 mutants to elicit the same phenotype by inhibiting signaling through activin receptors without disrupting BMP pathways.
Our experiments demonstrate that anterior development in Xenopus is very sensitive to inhibition of Smad2 signaling, suggesting that high levels of an activin/Vg1-like signal is required in anterior regions of the embryo to permit complete axis formation. These observations agree with recent experiments in the mouse in which disruption of Smad2 or ActRIB (ALK4) produces defects in proximaldistal patterning which precedes and is thought to dictate the anterior-posterior axis (Waldrip et al., 1998; Nomura and Li, 1998; Gu et al., 1998) . Furthermore, mice homozygous for the Smad2 allele Smad2
Robm1 show a complete loss of anterior-posterior patterning and chimeric experiments indicate that the absence of Smad2 in the extraembryonic tissues can account for this patterning defect. Although mesoderm induction still occurs, this mesoderm is entirely posterior in nature, forming only extraembryonic structures (Waldrip et al., 1998) . The role of Smad2 in mesoderm induction remains unclear since mice homozygous for other Smad2 alleles fail to form mesoderm Weinstein et al., 1998) . Mice deficient in Smad4 also fail to form mesoderm; however, this failure could be due to disruption of BMP signaling (Sirard et al., 1997; Yang et al., 1998) . Interestingly, chimeric embryos with wild-type extraembryonic tissues and Smad4-deficient embryonic tissues exhibit anterior truncations (Sirard et al., 1997) .
The precise identity of the TGF␤ factors involved in axial formation remains to be identified, although several candidates for this inductive activity include activin-like factors, Vg1, and nodals (Xnr). Specific disruption of Vg1 (Joseph and Melton, 1998) and activin (Dyson and Gurdon, 1997) ligands blocks dorsal-anterior development, but not ventralposterior tissues. In mice deletions of both Activin A and Activin B do not disrupt gastrulation (Matzuk et al., 1995) ; however, nodal has been shown to function in the primitive endoderm to regulate anterior development (Varlet et al., 1997) . Also, a genetic interaction between Smad2 and nodal has been reported in mice, suggesting that Smad2 mediates nodal signaling . The mammalian homologue of Vg1 has not been identified. Based on the similar biological effects of nodal and Vg1 compared to activins, it is likely that nodal and Vg1 also regulate Smad2-dependent signaling pathways. Supporting this suggestion we have demonstrated here that the Smad2 mutant proteins can inhibit Vg1 functions. Thus, regardless of the identity of the ligand(s) in vivo, our results implicate a conserved function for Smad2 signaling in mediating dorsoanterior axis formation in vertebrates.
